Financial StrategySolid balance sheet should provide ample runway to advance and expand the internal pipeline while executing on key strategic initiatives.
Research And DevelopmentTransition from platform to pipeline continues with two significant therapeutic antibodies entering clinical trials.
Strategic PartnershipsAbCellera succeeded in signing two new partnerships in 2024, with Biogen and venture firms Viking and ArrowMark, and expanding two legacy programs.